{"entity":{"type":"insider","cik":"0001995275","url":"/insider/0001995275","json_url":"/insider/0001995275.json","name":"Lennon David James","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":6,"first":"2024-10-03","last":"2026-04-10","span_basis":"filed_date"},"name_variants":[{"name":"Lennon David James","source":"filing","n_filings":6,"first_seen":"2024-10-03","last_seen":"2026-04-10"}],"transactions":[{"id":6232605,"accession":"0001995275-26-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001995275-26-000012","line_url":"/filing/0001995275-26-000012#line-1","is_derivative":false,"issuer_cik":"0001422142","issuer_name":"Whitehawk Therapeutics, Inc.","issuer_ticker":"WHWK","issuer_name_source":null,"issuer_url":"/issuer/0001422142","owner_cik":"0001995275","owner_name":"Lennon David James","owner_display_name":"Lennon David James","owner_url":"/insider/0001995275","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14500.0,"shares_display":"14,500","price_per_share":3.38,"price_display":"3.38","price_state":"stated","total_value":49010.0,"total_display":"49,010.00","total_whole":"49,010","shares_owned_after":518622.0,"shares_owned_after_display":"518,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-09","filed_date":"2026-04-10","scope":"insider"},{"id":6207713,"accession":"0001995275-26-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001995275-26-000008","line_url":"/filing/0001995275-26-000008#line-3","is_derivative":false,"issuer_cik":"0001422142","issuer_name":"Whitehawk Therapeutics, Inc.","issuer_ticker":"WHWK","issuer_name_source":null,"issuer_url":"/issuer/0001422142","owner_cik":"0001995275","owner_name":"Lennon David James","owner_display_name":"Lennon David James","owner_url":"/insider/0001995275","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63945.0,"shares_display":"63,945","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":217413.0,"total_display":"217,413.00","total_whole":"217,413","shares_owned_after":533122.0,"shares_owned_after_display":"533,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-08","filed_date":"2026-04-08","scope":"insider"},{"id":6207708,"accession":"0001995275-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001995275-26-000008","line_url":"/filing/0001995275-26-000008#line-2","is_derivative":false,"issuer_cik":"0001422142","issuer_name":"Whitehawk Therapeutics, Inc.","issuer_ticker":"WHWK","issuer_name_source":null,"issuer_url":"/issuer/0001422142","owner_cik":"0001995275","owner_name":"Lennon David James","owner_display_name":"Lennon David James","owner_url":"/insider/0001995275","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94087.0,"shares_display":"94,087","price_per_share":3.43,"price_display":"3.43","price_state":"stated","total_value":322718.41,"total_display":"322,718.41","total_whole":"322,718","shares_owned_after":597067.0,"shares_owned_after_display":"597,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-08","scope":"insider"},{"id":6207704,"accession":"0001995275-26-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001995275-26-000008","line_url":"/filing/0001995275-26-000008#line-1","is_derivative":false,"issuer_cik":"0001422142","issuer_name":"Whitehawk Therapeutics, Inc.","issuer_ticker":"WHWK","issuer_name_source":null,"issuer_url":"/issuer/0001422142","owner_cik":"0001995275","owner_name":"Lennon David James","owner_display_name":"Lennon David James","owner_url":"/insider/0001995275","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102395.0,"shares_display":"102,395","price_per_share":3.51,"price_display":"3.51","price_state":"stated","total_value":359406.45,"total_display":"359,406.45","total_whole":"359,406","shares_owned_after":691154.0,"shares_owned_after_display":"691,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-08","scope":"insider"},{"id":6067078,"accession":"0001995275-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001995275-26-000006","line_url":"/filing/0001995275-26-000006#line-2","is_derivative":false,"issuer_cik":"0001422142","issuer_name":"Whitehawk Therapeutics, Inc.","issuer_ticker":"WHWK","issuer_name_source":null,"issuer_url":"/issuer/0001422142","owner_cik":"0001995275","owner_name":"Lennon David James","owner_display_name":"Lennon David James","owner_url":"/insider/0001995275","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26858.0,"shares_display":"26,858","price_per_share":3.48,"price_display":"3.48","price_state":"stated","total_value":93465.84,"total_display":"93,465.84","total_whole":"93,466","shares_owned_after":793549.0,"shares_owned_after_display":"793,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-03","scope":"insider"},{"id":5830572,"accession":"0001995275-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001995275-26-000002","line_url":"/filing/0001995275-26-000002#line-2","is_derivative":false,"issuer_cik":"0001422142","issuer_name":"Whitehawk Therapeutics, Inc.","issuer_ticker":"WHWK","issuer_name_source":null,"issuer_url":"/issuer/0001422142","owner_cik":"0001995275","owner_name":"Lennon David James","owner_display_name":"Lennon David James","owner_url":"/insider/0001995275","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5100.0,"shares_display":"5,100","price_per_share":3.3096,"price_display":"3.31","price_state":"stated","total_value":16878.96,"total_display":"16,878.96","total_whole":"16,879","shares_owned_after":44579.0,"shares_owned_after_display":"44,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-10","scope":"insider"},{"id":4555664,"accession":"0001415889-25-006316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-006316","line_url":"/filing/0001415889-25-006316#line-2","is_derivative":false,"issuer_cik":"0001422142","issuer_name":"Aadi Bioscience, Inc.","issuer_ticker":"AADI","issuer_name_source":null,"issuer_url":"/issuer/0001422142","owner_cik":"0001995275","owner_name":"Lennon David James","owner_display_name":"Lennon David James","owner_url":"/insider/0001995275","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5690.0,"shares_display":"5,690","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":13371.5,"total_display":"13,371.50","total_whole":"13,372","shares_owned_after":33429.0,"shares_owned_after_display":"33,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-03","scope":"insider"},{"id":2257187,"accession":"0001415889-24-024676","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-024676","line_url":"/filing/0001415889-24-024676#line-2","is_derivative":false,"issuer_cik":"0001422142","issuer_name":"Aadi Bioscience, Inc.","issuer_ticker":"AADI","issuer_name_source":null,"issuer_url":"/issuer/0001422142","owner_cik":"0001995275","owner_name":"Lennon David James","owner_display_name":"Lennon David James","owner_url":"/insider/0001995275","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9689.0,"shares_display":"9,689","price_per_share":1.94,"price_display":"1.94","price_state":"stated","total_value":18796.66,"total_display":"18,796.66","total_whole":"18,797","shares_owned_after":22869.0,"shares_owned_after_display":"22,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-03","filed_date":"2024-10-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001422142","name":"Whitehawk Therapeutics, Inc.","url":"/issuer/0001422142","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","n_filings":6,"first_seen":"2024-10-03","last_seen":"2026-04-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001995275","retrieved_at":"2026-08-23T03:39:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}